Abstract
Optimizing appropriate pharmacologic therapy in patients with congestive heart failure has been difficult due to a lack of easily obtainable hemodynamic information to guide the approach to the patient. Recently, thoracic electrical bioimpedance has allowed reliable outpatient determination of these hemodynamic variables, potentially allowing tailored adjustment of therapy in patients with cardiac dysfunction. Case studies are presented in which bioimpedance data were important contributing factors in optimizing patient management. Utilization of this new technology to individualize patient therapy should lead to improved outcomes and more efficient use of health care resources. (c)2000 by CHF, Inc.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
